Wuhan Easy Diagnosis Biomedicine Co.,Ltd.’s Net Profit Rose 376.8% in First Half of 2022

Wuhan Easy Diagnosis Biomedicine Co.,Ltd. (武汉明德生物科技股份有限公司) (002932.SZ) reported a net profit of 2.8 billion yuan in the first half of 2022, up 376.8% year-on-year.

Meanwhile, the company posted 5.3 billion yuan in revenue, up 360.3% year-on-year.

At the end of the reporting period, it had 6.5 billion yuan in total assets and 1.1 billion yuan in total liabilities, with a liability-to-asset ratio of 16.4%.